Ellagic acid was also reported to lower TNF-α and IL-1β levels in diabetic nephropathy and nephrotoxicity kidney injury mice, which might be mediated through NF-κB; therefore, ellagic acid could be a potent inhibitor of NF-κB activation [211,213]. Here, NFKB1 is linked to diabetic kidney disease.